A detailed history of West End Advisors, LLC transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, West End Advisors, LLC holds 1 shares of LH stock, worth $203. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$203
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

BUY
$201.05 - $221.7 $201 - $221
1 New
1 $0
Q3 2022

Oct 27, 2022

BUY
$204.81 - $262.19 $204 - $262
1 New
1 $0
Q2 2022

Jul 28, 2022

BUY
$213.86 - $277.87 $213 - $277
1 New
1 $234,000
Q3 2021

Oct 26, 2021

SELL
$274.82 - $308.34 $274 - $308
-1 Closed
0 $0
Q2 2021

Jul 15, 2021

BUY
$251.87 - $278.14 $251 - $278
1 New
1 $275,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $18.2B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track West End Advisors, LLC Portfolio

Follow West End Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.